Lipid-related anti-cancer drug resistance of lung adenocarcinoma cells Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021
Does acute phase protein alpha1-antitrypsin modulate apoptosis-autophagy crosstalk resulting in resistance of NSCLC cells to cancer drugs? Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021
The role of NHE-1 on multidrug-resistance mechanisms of human small cell lung cancer cells Source: Eur Respir J 2007; 30: Suppl. 51, 537s Year: 2007
The role of radiation therapy in the management of small cell lung cancer Source: Breathe, 13 (4) e87; 10.1183/20734735.009617 Year: 2017
The effect of new drug-resistance antisense gene on multidrug resistance mechanism of drug-resistant human small cell lung cancer cells Source: Eur Respir J 2007; 30: Suppl. 51, 715s Year: 2007
Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer Source: Eur Respir J 2002; 19: 557-570 Year: 2002
The selection of candidate microRNA biomarkers of acquired drug resistance in the lung adenocarcinoma cells treated with EGFR TKI Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019
Epithelial cell migration as a potential therapeutic target in early lung cancer Source: Eur Respir Rev 2017; 26: 160069 Year: 2017
Modified sensitivity of alveolar cells to TRAIL-mediated apoptosis: a mechanism involved in emphysema pathogenesis with a potential impact on cancer therapy research Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy Source: Eur Respir J, 53 (3) 1801562; 10.1183/13993003.01562-2018 Year: 2019
The human endogenous antibiotic LL-37 promotes growth of lung cancer cells Source: Eur Respir J 2006; 28: Suppl. 50, 153s Year: 2006
Roles of volume-sensitive Cl- channel in cisplatin resistance of human lung adenocarcinoma cells Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
The role of Pgp, MRP and LRP expression in chemotherapy response of small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004
Dynamic monitoring of plasma DAMP proteins during various anticancer agents in advanced lung cancer patients Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020
The biology of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=61 Year: 2001
Does the incorporation of new generation cytotoxic agent improve the overall outcome in inoperable nonsmall cell lung cancer (NSCLC)? Source: Eur Respir J 2003; 22: Suppl. 45, 64s Year: 2003
New chemotherapeutic agents Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=259 Year: 2001
IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer Source: Eur Respir J , 49 (4) 1600711; DOI: 10.1183/13993003.00711-2016 Year: 2017
Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutations Source: Eur Respir J 2015; 46: 19-21 Year: 2015